Professor, Surgery, Virginia Commonwealth University, Medical College of Virginia School of Medicine
Medical Genetics
Dr. Pamela M. Kimball, PHD
|
|
Give Review
Dr. Pamela M. Kimball, PHD works in the field of Medical Genetics. She went to University of Alabama School of Medicine. University of Alabama School of Medicine is ranked 37 in research and 17 in primary care medicine Doctor Pamela M. Kimball, PHD is a published doctor and has 50 publications published. The lastest was: 'A prospective randomized trial of mycophenolate mofetil with neoral or tacrolimus after orthotopic liver transplantation.'
Publications
- Pregnancy-related allograft rejection following heart transplant.
- Graft-versus-host disease after solid organ transplantation: a single center experience and review of literature.
- CXCR3 Expression Elevated on Peripheral CD8(+) Lymphocytes from HIV/HCV Coinfected Individuals.
- Surveillance of alloantibodies after transplantation identifies the risk of chronic rejection.
- Organ procurement and transplantation network/united network for organ sharing histocompatibility committee collaborative study to evaluate prediction of crossmatch re...
- Cellular immunity impaired among patients on left ventricular assist device for 6 months.
- Emergence of IgG3 alloantibody after renal transplantation associated with early graft failure.
- Quantitation of alloantibody concentration can predict patient sensitivity to intravenous immunoglobulin desensitization.
- 14th International HLA and Immunogenetics Workshop: report on the Prospective Chronic Rejection Project.
- Desensitized renal transplant recipients show reduced cellular responses to in vitro challenge.
- T-cell response to staphylococcal enterotoxin B is reduced among heart failure patients on ventricular device support.
- Allograft TNFbeta and IL16 polymorphisms influence HCV recurrence and severity after liver transplantation.
- Elevated B-cell autoantibodies among HIV+ transplant candidates: crossmatch implications.
- DR antigens influence graft outcome and HCV recurrence after liver transplantation.
- HCV core protein augments cyclosporine immunosuppression.
- Living donor liver transplant with clinical tolerance, laboratory evidence of chimerism, and spontaneous clearance of HBV.
- Comparison of 125I-interferon-alpha binding to peripheral blood cells from African-Americans and Caucasians with hepatitis C.
- Comparison of two drug regimens upon clinical outcome among renal transplant recipients with positive flow cytometric crossmatches.
- Proliferative suppression and class I insufficiency on peripheral blood cells from hepatitis C patients overcome by exogenous cytokines or high-dose mitogen.
- Tumor necrosis factor beta gene polymorphisms associated with urinary tract infections after renal transplantation.
- Ethnicity and cytokine production gauge response of patients with hepatitis C to interferon-alpha therapy.
- Influenza vaccination among heart transplant recipients.
- Alpha interferon combined with ribavirin potentiates proliferative suppression but not cytokine production in mitogenically stimulated human lymphocytes.
- Influenza vaccination does not promote cellular or humoral activation among heart transplant recipients.
- Frequency, potential risk and therapeutic intervention in end-stage renal disease patients with antiphospholipid antibody syndrome: a multicenter study.
- Changes in cell cycling and apoptosis contribute to reduced effector cell generation among long-term heart transplant survivors.
- A prospective randomized trial of mycophenolate mofetil with neoral or tacrolimus after orthotopic liver transplantation.
- Flow cross-matching identifies patients at risk for postoperative elaboration of cytotoxic antibodies.
- Lethal graft-versus-host disease after simultaneous kidney-pancreas transplantation.
- The impact of race and HLA matching on long-term survival following cardiac transplantation.
- The impact of a positive crossmatch upon outcome after liver transplantation.
- Disproportionate HLA matching may contribute to racial disparity in patient survival following cardiac transplantation.
- Early results of infrageniculate arterial reconstruction using cryopreserved homograft saphenous conduit (CADVEIN) and combination low-dose systemic immunosuppression.
- The paradox of cytokine monitoring-predictor of immunologic activity as well as immunologic silence following cardiac transplantation.
- Cytokine panel predicts early rejection and therapeutic response after cardiac transplantation.
- Effect of IgM-positive crossmatches on survival in heart transplant recipients.
- The relationship among donor-recipient HLA mismatches, rejection, and death from coronary artery disease in cardiac transplant recipients.
- Positive pretransplant crossmatches predict early graft loss in liver allograft recipients.
- Influence of HLA matching on rejections and short- and long-term primary cadaveric allograft survival.
- Immune risk factors: impact on the incidence and diagnosis of rejection.
- Cyclosporine and rapamycin affect protein kinase C induction of the intracellular activation signal, activator of DNA replication.
- Stability of renal allograft glomerular filtration rate associated with long-term use of cyclosporine A.
- Influence of race on crossmatch outcome and recipient eligibility for transplantation.
- Failure of prolyl-peptidyl isomerase to mediate cyclosporine suppression of intracellular activation signal generation.
- Production of synergistic but nonidentical mechanisms of immunosuppression by rapamycin and cyclosporine.
- Possible contribution of pretransplant immune responder status to renal allograft survival differences of black versus white recipients.
- Improved renal allograft survival for AHG and DTE/AHG crossmatch-negative recipients.
- AHG and DTE/AHG procedure identification of crossmatch-appropriate donor-recipient pairings that result in improved graft survival.
- Sensitivity of intracellular signals responsible for cell cycle progression to cyclosporine.
Doctors Specialties
- Medical Genetics
Accepted Insurances
Education
-
University of Alabama School of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Margie L. Jaworski, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arti Pandya, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Raymond C. Lewandowski Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Judith A. Hiemenga, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Walter E. Nance, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. John M. Quillin, PHD |